Search

Now showing items 1-10 of 26

Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.

Chang, P; Fonarow, GC; Freeman, J; Gersh, Bernard John; Go, AS; Jackson, Larry Ronald II; Kim, SH; ... (14 authors) (Clin Cardiol, 2016-02)

BACKGROUND: Patients with sinus node dysfunction (SND) have increased risk of atrial tachyarrhythmias, including atrial fibrillation (AF). To date, treatment patterns and outcomes of patients with SND and AF have not been ...

Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.

Fosbøl, Emil; Gersh, Bernard John; Holmes, DaJuanicia; Kowey, Peter R; Mahaffey, Kenneth William; Mills, RM; ORBIT-AF Investigators and Patients; ... (11 authors) (J Am Heart Assoc, 2013-07-18)

BACKGROUND: The prevalence of atrial fibrillation (AF) continues to increase; however, there are limited data describing the division of care among practitioners in the community and whether care differs depending on provider ...

Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Ansell, J; Chang, P; Fonarow, GC; Gersh, Bernard John; Kim, S; Kowey, Peter R; Mahaffey, Kenneth William; ... (13 authors) (Circulation, 2015-02-03)

BACKGROUND: Temporary interruption of oral anticoagulation for procedures is often required, and some propose using bridging anticoagulation. However, the use and outcomes of bridging during oral anticoagulation interruptions ...

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Chang, P; Gersh, Bernard John; Holmqvist, Fredrik Nils; Hong, SJ; Kowey, Peter R; Naccarelli, GV; ORBIT-AF Investigators; ... (12 authors) (J Am Heart Assoc, 2015-05-21)

BACKGROUND: The characteristics of patients undergoing atrial fibrillation (AF) ablation and subsequent outcomes in community practice are not well described. METHODS AND RESULTS: Using the Outcomes Registry for Better Informed ...

Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization.

Hess, Connie Ng; Hellkamp, Anne; Roe, Matthew Todd; Thomas, Laine Elliott; Scirica, BM; Peng, SA; Peterson, Eric David; ... (8 authors) (J Am Heart Assoc, 2016-03-14)

BACKGROUND: While use of P2Y12 receptor inhibitor is recommended by guidelines, few studies have examined its effectiveness among older non-ST-segment elevation myocardial infarction patients who did not undergo coronary ...

Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.

Hess, Connie Ng; McCoy, LA; Duggirala, HJ; Tavris, DR; O'Callaghan, K; Douglas, Pamela Susan; Peterson, Eric David; ... (8 authors) (J Am Heart Assoc, 2014-02-07)

BACKGROUND: Data regarding sex-based outcomes after percutaneous coronary intervention (PCI) for myocardial infarction are mixed. We sought to examine whether sex differences in outcomes exist in contemporary practice. METHODS ...

Contemporary trends and predictors of postacute service use and routine discharge home after stroke.

Prvu Bettger, Janet; McCoy, L; Smith, EE; Fonarow, GC; Schwamm, LH; Peterson, Eric David (J Am Heart Assoc, 2015-02-23)

BACKGROUND: Returning home after the hospital is a primary aim for healthcare; however, additional postacute care (PAC) services are sometimes necessary for returning stroke patients to their pre-event status. Recent trends ...

Heart rate is associated with progression of atrial fibrillation, independent of rhythm.

Chang, P; Fonarow, GC; Freeman, JV; Gersh, Bernard John; Holmqvist, Fredrik Nils; Kim, S; Kowey, Peter R; ... (15 authors) (Heart, 2015-06)

OBJECTIVE: Atrial fibrillation (AF) often progresses from paroxysmal or persistent to more sustained forms, but the rate and predictors of AF progression in clinical practice are not well described. METHODS: Using the Outcomes ...

Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.

Britz, GW; Constable, M; Cox, M; Fonarow, GC; Lin, CB; Olson, DaiWai M; Peterson, Eric David; ... (9 authors) (J Am Heart Assoc, 2015-07-22)

BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is ...

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Arbetter, D; Bode, C; Burton, P; Chi, G; Cohen, M; Daaboul, Y; Fox, KAA; ... (19 authors) (Circulation, 2017-01-24)

BACKGROUND: Patients with atrial fibrillation who undergo intracoronary stenting traditionally are treated with a vitamin K antagonist (VKA) plus dual antiplatelet therapy (DAPT), yet this treatment leads to high risks of ...